Central Hospital, Nancy, France: Shock, Cardiogenic trials

The registry lists 13 Shock, Cardiogenic studies with Central Hospital, Nancy, France as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 3 2Phase 4 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Recurrent Ventricular Arrythmias in ICUNot yet recruitingNCT07033065
• Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.RecruitingNCT05879276Phase 3
• Effect of Early Empagliflozin Initiation in Cardiogenic Shock.Active, not recruitingNCT07450417
• Left Ventricular Outflow Tract Mean Velocity in Children: a Strong Alternative to Cardiac Index in Pediatric Intensive Care UnitCompletedNCT06837727
• Evaluation of the 1-year Prognosis of Patients Under Veno-arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock With Blood Transfusion RequirementStatus unknownNCT05696210
• Safety Profile of the Combination of Levosimendan and IV Beta Blocker in Cardiogenic Shock: a Retrospective StudyStatus unknownNCT04938375
• Lower Limb Surveillance During VA-ECLSCompletedNCT03910062
• Veno-arterial Extracorporeal Membrane Oxygenation Prior to Left Ventricular Assist Device Implantation.Status unknownNCT03583970
• Norepinephrine vs Norepinephrine and Dobutamine in Cardiogenic ShockStatus unknownNCT03340779Phase 3
• Impact of Adrenoreceptor Expressions on Inflammatory Pattern in Refractory Cardiogenic Shock Under VA ECMOCompletedNCT03327493Not applicable
• Epidemiology and Prognostic of the Acute Heart FailureStatus unknownNCT02880358
• Effects of Induced Moderate HYPOthermia on Mortality in Cardiogenic Shock Patients Rescued by Veno-arterial ExtraCorporeal Membrane Oxygenation (ECMO)CompletedNCT02754193Not applicable
• Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic ShockCompletedNCT01367743Phase 4